Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1501-1512 of 2022 results
Page 126 of 169
Key Publications November 6, 2012

Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease: A Rationale for Increased Efforts to Understand its Pathophysiology and Develop Targeted Therapies.

J Am Coll Cardiol 2012;60:716-21

Tsimikas S, Hall JL
Genetics Lipids/Lipoproteins
Key Publications November 6, 2012

Lipid-immunity cross-talk: a role for adipocyte fatty acid binding protein?

Arterioscler Thromb Vasc Biol 2012;32:2043-4

Pasterkamp G
Inflammation Lipids/Lipoproteins
Key Publications November 5, 2012

Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.

Am J Cardiol 2012;110:662-5

Malave H, Castro M, Burkle J, Voros S, Dayspring T, Honigberg R, Pourfarzib R
Diabetes Lipids/Lipoproteins
Key Publications November 2, 2012

Mendelian randomisation, lipids, and cardiovascular disease.

Lancet 2012;380:543-5

Harrison SC, Holmes MV, Humphries SE
Genetics Lipids/Lipoproteins
Key Publications November 2, 2012

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.

Lancet 2012;380:572-80

Voight BF, Peloso GM, Orho-Melander M et al.
Genetics Lipids/Lipoproteins
Key Publications November 2, 2012

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

Lancet 2012;380:581-90

Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C
Lipids/Lipoproteins Prevention
Key Publications November 1, 2012

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.

Lancet 2012;380:565-71

Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ
Diabetes Lipids/Lipoproteins
Key Publications November 1, 2012

Balancing the cardiometabolic benefits and risks of statins.

Lancet 2012;380:541-3

Watts GF, Ooi EM
Diabetes Lipids/Lipoproteins
Key Publications October 30, 2012

Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.

J Lipid Res 2012;53:1755-66

Barter PJ, Rye KA
Lipids/Lipoproteins Metabolism
Key Publications October 29, 2012

New lipid and lipoprotein targets for the treatment of cardiometabolic diseases.

J Lipid Res 2012;53:1719-21

Hazen SL
Cardiometabolic Risk Lipids/Lipoproteins
Key Publications October 25, 2012

Angiographically-assessed coronary artery disease associates with HDL particle size in women.

Atherosclerosis 2012;223:359-64

Blackburn P, Lemieux I, Lamarche B, Bergeron J, Perron P, Tremblay G, Gaudet D, Després JP
Lipids/Lipoproteins Metabolic Syndrome
Key Publications October 24, 2012

ApoE and the role of very low density lipoproteins in adipose tissue inflammation.

Atherosclerosis 2012;223:342-9

Wang J, Perrard XD, Perrard JL, Mukherjee A, Rosales C, Chen Y, Smith CW, Pownall HJ, Ballantyne CM, Wu H
Adipose Tissue Inflammation Lipids/Lipoproteins
of 169